Antibiotics and timing in infectious disease in the emergency department;Antibióticos y el factor tiempo en la infección en urgencias

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 31, Issue 3, 2013, Pages 173-180

  González Castillo, Juan ^a   Candel, Francisco Javier ^a   Julián Jiménez, Agustín ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

Antibiotics; Bacteremia; Emergency department; Meningitis; Pneumonia; Procalcitonin; Sepsis; Time; Treatment

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CHRONOTHERAPY; EMERGENCY CARE; EMERGENCY WARD; EVIDENCE BASED PRACTICE; HUMAN; INFECTION; MEDICAL LITERATURE; MORTALITY;

EID: 84875229915     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2012.01.025     Document Type: Review

References (89)

1. Grupo para el Estudio de la Infección en Urgencias Estudio epidemiológico de las infecciones en el Área de Urgencias Emergencias 12 2000 80 89
2. U. Geary, and U. Kennedy Toma de decisiones clínicas en Medicina de Urgencias y Emergencias Emergencias 22 2010 56 60
3. P.M. Olaechea, F. Álvarez-Lerma, M. Sánchez, A. Torres, M. Palomar, and P. Fernández Evaluación del estado de gravedad de pacientes con infecciones graves. Criterios de ingreso en unidades de cuidados intensivos Enferm Infecc Microbiol Clin 27 2009 342 352
4. C. León, L. García-Castrillo, M. Moya, A. Artigas, M. Borges, and F.J. Candel Documento de consenso (SEMES-SEMICYUC). Recomendaciones del manejo diagnóstico-terapéutico inicial y multidisciplinario de la sepsis grave en los servicios de urgencias hospitalarios Med Intensiva 31 2007 375 387
5. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, and R. Jaeschke Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
6. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, and N.C. Dean Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults Clin Infect Dis 44 2007 S27 S72
7. R. Menéndez, A. Torres, J. Aspa, A. Capelastegui, C. Prat, F. Rodríguez de Castro Sociedad Española de Neumología y Cirugía Torácica Neumonía adquirida en la comunidad. Nueva normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Arch Bronconeumol 46 2010 543 558
8. D. Lepur, and B. Barsic Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome Infection 35 2007 225 231
9. D. Van de Beek, J. De Gans, and A.R. Tunkel Community-acquired bacterial meningitis in adults N Engl J Med 354 2006 44 53
10. M. Ben-Yakov, S. Eftekhary, A. Kiss, and M.J. Schull La extracción de un hemograma antes de la valoración médica retrasa la administración de antibióticos en los pacientes con fiebre neutropénica en urgencias Emergencias 22 2010 429 434
11. S. Tomás, M. Chanovas, F. Roqueta, J. Alcaraz, T. Toranzo y grupo de trabajo EVADUR-SEMES EVADUR: eventos adversos ligados a la asistencia en los servicios de urgencias de hospitales españoles Emergencias 22 2010 415 428
12. G.S. Martin, and D.M. Mannino The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546 1554
13. V. Nobre, F.P. Sarasin, and J. Pugin Prompt antibiotic administration and goal-directed hemodynamic support in patients with severe sepsis and septic shock Curr Opin Crit Care 13 2007 586 591
14. A. Davies, C. Green, and J. Hutton Severe sepsis: a European estimate of the burden of disease in ICU Int Care Med 27 2001 S284
15. A. Kumar, D. Roberts, K.E. Wood, B. Light, J.E. Parrillo, and S. Sharma Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 2006 1589 1596
16. J. Laché, E. Azoulay, F. Fieux, L. Mesnard, D. Moreau, and G. Thiery Improved survival of critically ill cancer patients with septic shock Intensive Care Med 29 2003 1688 1695
17. D.F. Gaieski, M.E. Mikkelsen, R.A. Band, J.M. Pines, R. Massone, and F.F. Furia Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department Crit Care Med 38 2010 1045 1053
18. A. Lieb, J. Showalter, and R. Cherry Time from hospital arrival to administration of antibiotics: effect on mortality in septic patients Crit Care Med 38 Suppl. 2010 704
19. J. Garnacho-Montero, T. Aldabo-Pallas, C. Garnacho-Montero, A. Cayuela, R. Jiménez, and S. Barros Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis Crit Care 10 2006 R111
20. S. Siddiqui, N. Salahuddin, A. Raza, and J. Razzak How early do antibiotics have to be to impact mortality in severe sepsis? A prospective, observational study from an emergency department J Ayub Med Coll Abbottabad 21 2009 106 110
21. E. Rivers, B. Nguyen, S. Havstad, J. Ressler, A. Muzzin, and B. Knoblich Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 2001 1368 1377
22. A.G. Sousa, C.J. Fernandes Junior, G.P.D. Santos, C.R. Laselva, J. Polessi, and L.F. Lisboa The impact of each action in the Surviving Sepsis Campaign measures on hospital mortality of patients with severe sepsis/septic shock Einstein 6 2008 323 327
23. R. Ferrer, A. Artigas, D. Suarez, E. Palencia, M.M. Levy, and A. Arenzana Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study Am J Respir Crit Care Med 180 2009 861 866
24. M.A. Puskarich, S. Trzeciak, N.I. Shapiro, R.C. Arnold, J.M. Horton, J.R. Studnek On behalf of the Emergency Medicine Shock Research Network (EMSHOCKNET) Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol Crit Car Med 39 2011 2066 2071
25. C.R. Flores La saturación de los servicios de urgencias: una llamada a la unidad Emergencias 23 2011 59 64
26. T.P. Meehan, M.J. Fine, H.M. Krumholz, J.D. Scinto, D.H. Galusha, and J.T. Mockalis Quality of care, process, and outcomes in elderly patients with pneumonia JAMA 278 1997 2080 2084
27. P.M. Houck, D.W. Bratzler, W. Nsa, A. Ma, and J.G. Bartlett Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia Arch Intern Med 164 2004 637 644
28. I. Alfageme, J. Aspa, S. Bello, J. Blanquer, R. Blanquer, L. Borderías SEPAR Working Group on Community-Acquired Pneumonia Tuberculosis and Respiratory Infections (TIR) Assembly. Guidelines for the Diagnosis and Treatment of Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Arch Bronconeumol 41 2005 272 289
29. C.M. Berjohn, N.O. Fishman, M.M. Joffe, P. Edelstein, and J.P. Metlay Treatment and outcomes for patients with bacteremic pneumococcal pneumonia Medicine 87 2008 160 166
30. J.M. Querol-Ribelles, J.M. Tenías, R. Forés, G. Vila, A. Lillo, and M. Beneyto Demora del tratamiento antibiótico y evolución de los pacientes con neumonía adquirida en la comunidad que requieren hospitalización Med Clin (Barc) 130 2008 366 370
31. D.R. Ziss, A. Stowers, and C. Feild Community-acquired pneumonia: compliance with Centers for Medicare and Medicaid Services, national guidelines, and factors associated with outcome South Med J 96 2003 949 959
32. M. Bodi, A. Rodriguez, J. Sole-Violan, M.C. Gilavert, J. Garnacho, and J. Blanquer Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival Clin Infect Dis 41 2005 1709 1716
33. T.J. Marrie, and L. Wu Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU Chest 127 2005 1260 1270
34. A.H. Bruns, J.J. Oosterheert, W.N. Hustinx, C.A. Gaillard, E. Hak, and A.I. Hoepelman Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia Eur J Clin Microbiol Infect Dis 28 2009 913 919
35. J.M. Pines, J.A. Isserman, and P.B. Hinfey The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine J Emerg Med 37 2009 335 340
36. K.T. Yu, and P.C. Wyer Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia Ann Emerg Med 51 2008 651 662
37. J.A. Welker, M. Huston, and J.D. McCue Antibiotic timing and errors in diagnosing pneumonia Arch Intern Med 168 2008 351 356
38. M. Kanwar, N. Brar, R. Khatib, and M.G. Fakih Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule Chest 131 2007 1865 1869
39. E. García, S. Soto, A. Hernández-Torres, J.A. Herrero, and J. Gómez Estudio de una cohorte de pacientes con neumonía adquirida en la comunidad de bajo riesgo ingresados en un hospital universitario Emergencias 22 2010 275 281
40. A. Julián-Jiménez, F.J. Candel, P. Piñera, J. González del Castillo, M.S. Moya, and M. Martínez Recomendaciones INFURG-SEMES: manejo de la infección respiratoria de vías bajas en urgencias Monografías de Emergencias 3 2009 1 21
41. J.A. Muszynski, N.L. Knatz, C.L. Sargel, S.A. Fernández, D.J. Marquardt, and M.W. Hall Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial community-acquired pneumonia in children Pediatr Infect Dis J 30 2011 295 301
42. P.M. Houck, and D.W. Bratzler Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes? Curr Opin Infect Dis 18 2005 151 156
43. J. Vallés, E. Mesalles, D. Mariscal, M. del Mar Fernández, R. Peña, and J.L. Jiménez A 7-year study of severe hospital-acquired pneumonia requiring ICU admission Intensive Care Med 29 2003 1981 1988
44. A. Julián-Jiménez ¿Cuándo y dónde ingresar las neumonías adquiridas en la comunidad? Emergencias 23 2011 161 163
45. Sl. Aronin, P. Peduzzi, and V.J. Quagliarello Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing Ann Intern Med 129 1998 862 869
46. N. Proulx, D. Fréchette, B. Toye, J. Chan, and S. Kravcik Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis QJM 98 2005 291 298
47. D.A. Talan, and J. Zibulewsky Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis Ann Emerg Med 22 1993 1733 1738
48. V.J. Quagliarello, and M.J. Scheld Treatment of bacterial meningitis N Engl J Med 336 1997 708 716
49. M.G. Codina, M. de Cueto, D. Vicente, J.E. Echevarría, and G. Prats Diagnóstico microbiológico de las infecciones del sistema nervioso central Enferm Infecc Microbiol Clin 29 2011 127 134
50. M.H. Lebel Adverse outcome of bacterial meningitis due to delayed sterilization of cerebrospinal fluid Antibiot Chemother 45 1992 226 238
51. J.R. Miner, W. Heegaard, A. Mapes, and M. Biros Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center J Emerg Med 21 2001 387 392
52. W.L. Meadow, J. Lantos, R.R. Tanz, D. Mendez, R. Unger, and P. Wallskog Ought "standard care" be the "standard of care"'? A study of the time to administration of antibiotics in children with meningitis Am J Dis Child 147 1993 40 44
53. A.S. Hussein, and S.D. Shafran Acute bacterial meningitis in adults. A 12-year review Medicine 79 2000 360 368
54. K. Cartwright, S. Reilly, D. White, and J. Stuart Early treatment with parenteral penicillin in meningococcal disease BMJ 305 1992 143 147
55. N. Barquet, P. Domingo, J.A. Caylà, J. González, C. Rodrigo, P. Fernández-Viladrich Barcelona Meningococcal Disease Surveillance Group Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis Arch Intern Med 159 1999 2329 2340
56. M. Radetsky Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis Pediatr Infect Dis J 11 1992 694 698
57. J.M. Pines Timing of antibiotics for acute severe infections Emerg Med Clin N Am 26 2008 245 257
58. M. Daza, E. Cabot, F. Casarramona, J. Bassa, J. Bigas, and C. Miret Utilidad de la reacción en cadena de la polimerasa (PCR) para enterovirus en el diagnóstico de meningitis aséptica. Análisis de un brote con 17 casos confirmados Emergencias 22 2010 199 202
59. F.J. Candel, F. Martínez-Sagasti, M. Matesanz, J. González de Castillo, F. Ortuño, and F.J. Martín Detección y manejo inicial del Síndrome de Respuesta Inflamatoria Sistémica en las Urgencias de Medicina. Análisis de 24 horas en un hospital general An Med Interna 25 2008 205 208
60. C.C. Lai, S.Y. Chen, C.Y. Wang, J.Y. Wang, C.P. Su, and C.H. Liao Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department J Am Geriatr Soc 58 2010 518 522
61. L. Kobayashi, A. Konstantinidis, S. Shackelford, L.S. Chan, P. Talving, and K. Inaba Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity J Trauma 71 2011 1400 1405
62. A. Boyer, F. Vargas, F. Coste, E. Saubusse, Y. Castaing, and G. Gbikpi-Benissan Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management Intensive Care Med 35 2009 847 853
63. C.H. Wong, L.W. Khin, K.S. Heng, K.C. Tan, and C.O. Low The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections Crit Care Med 32 2004 1535 1541
64. B. Plicht, R.A. Jánosi, T. Buck, and R. Erbel Infective endocarditis as cardiovascular emergency Internist (Berl) 51 2010 987 994
65. E. Revuelta Monoartritis en urgencias Emergencias 23 2011 218 225
66. E.H. Ibrahim, G. Sherman, S. Ward, V.J. Fraser, and M.H. Kollef The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 118 2000 146 155
67. M.H. Kollef, G. Sherman, S. Ward, and V.J. Fraser Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 1999 462 474
68. S. Riedel, J.H. Melendez, A.T. An, J.E. Rosenbaum, and J.M. Zenilman Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department Am J Clin Pathol 135 2011 182 189
69. A. Lacoma, C. Prat, and V. Ausina Relevancia de los marcadores de inflamación en el diagnóstico, pronóstico y nuevas formas de tratamiento de las enfermedades infecciosas Enferm Infecc Microbiol Clin 28 2010 263 265
70. M.H. Kim, G. Lim, S.Y. Kang, W.I. Lee, J.T. Suh, and H.J. Lee Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever Yonsei Med J 52 2011 276 281
71. A. Julián-Jiménez, M.J. Palomo, R. Ortíz, A. Pedrosa, R. Parejo, and R. Salcedo Utilidad de la procalcitonina y la proteína C reactiva en el paciente con sepsis en urgencias Emergencias 21 2009 23 27
72. E. Aznar-Oroval, M. Sánchez-Yepes, P. Lorente-Alegre, M.C. San Juan-Gadea, B. Ortiz-Muñoz, and P. Pérez-Ballestero Valor diagnóstico de la procalcitonina, la interleucina 8, la interleucina 6 y la proteína C reactiva en la detección de bacteriemia y fungemia en pacientes con cáncer Enferm Infecc Microbiol Clin 28 2010 273 277
73. A. Julián-Jiménez, M.J. Palomo, J.G. Sentenac, and J. Aguilar Utilidad de la procalcitonina y la proteína C reactiva en la neumonía adquirida en la comunidad en urgencias Enferm Infecc Microbiol Clin 28 2010 661 667
74. R. Zaragoza, A. Artero, J.J. Camarena, S. Sancho, R. González, and J.M. Nogueira The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit Clin Microbiol Infect 9 2003 412 418
75. J. Garnacho-Montero, J.L. García-Garmendia, A. Barrero-Almodovar, F.J. Jiménez-Jiménez, C. Pérez-Paredes, and C. Ortiz-Leyba Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis Crit Care Med 31 2003 2742 2751
76. F. Alvarez-Lerma Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group Intensive Care Med 22 1996 387 394
77. P. Montravers, R. Gauzit, C. Muller, J.P. Marmuse, A. Fichelle, and J.M. Desmonts Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy Clin Infect Dis 23 1996 486 494
78. J.W. Chow, D.M. Fine, D.M. Shlaes, J.P. Quinn, D.C. Hooper, and M.P. Jonhson Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy Ann Intern Med 115 1991 585 590
79. J. Romero-Vivas, M. Rubio, C. Fernández, and J.J. Picazo Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus Clin Infect Dis 21 1995 1417 1423
80. V.C. Chang, C.C. Huang, S.T. Wang, and C.C. Chio Risk factor of complications requiring neurosurgical intervention in infants with bacterial meningitis Pediatr Neurology 17 1997 144 149
81. C.H. Heath, D.I. Grove, and D.F. Looke Delay in appropriate therapy of Legionella pneumonia associated with increased mortality Euro J Clin Microbiol Infect Dis 15 1996 286 290
82. L. Leibovici, M. Paul, O. Poznanski, M. Drucker, Z. Samra, and H. Konigsberger Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study Antimicrob Agents Chemother 41 1997 1127 1133
83. J.A. Martínez, N. Cobos-Trigueros, A. Soriano, M. Almela, M. Ortega, and F. Marco Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms Antimicrob Agents Chemother 54 2010 3590 3596
84. M. Paul Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis Cochrane Database Syst Rev 25 2006 CD003344
85. A. Kumar, R. Zarychanski, B. Light, J. Parrillo, D. Maki, D. Simon Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis Crit Care Med 38 2010 1773 1785
86. X. Jiménez, J.L. Espila, and J. Gallardo Códigos de activación: pasado, presente y futuro en España Emergencias 23 2011 311 318
87. M.I. Restrepo, E.M. Mortensen, G.W. Waterer, R.G. Wunderink, J.J. Coalson, and A. Anzueto Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Eur Respir J 33 2009 153 159
88. C.R. Frei, R.T. Attridge, E.M. Mortensen, M.I. Restrepo, Y. Yu, and C.U. Oramasionwu Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit Clin Ther 32 2010 293 299
89. G.Y. Larsen, N. Mecham, and R. Greenberg An emergency department septic shock protocol and care guideline for children initiated at triage Pediatrics 127 2011 e1585 e1592